[Modifications of dyslipemia of atherosclerotic origin using pentosan polysulphonic ester].
D001161:Arteriosclerosis / Q000188:drug therapy*; D002219:Carbamates / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D008055:Lipids / Q000097:blood*
D002219:Carbamates; D008055:Lipids
Modificaciones de la dislipemia de origen ateroscleroso por el éster pentosanpolisulfónico.